How does Malarone work? Atovaquone/proguanil malaria prevention explained

What does Malarone do?

Malarone contains atovaquone and proguanil, two antimalarial medicines. The combination is used for prevention and treatment of Plasmodium falciparum malaria under different regimens. Prevention tablets are not a substitute for urgent assessment and a treatment plan if you become ill.

Whether preventive medication is needed depends on the exact itinerary, travel dates, health and other medicines. The CDC Yellow Book 2026 malaria chapter explains this destination-specific approach.

Understanding the prevention schedule

The UK Malarone adult-tablet product information describes daily prevention beginning one to two days before entering a malaria-risk area, continuing during exposure and for seven days after leaving it. A clinician must confirm the prescribed tablet and schedule; paediatric and adult tablets contain different amounts.

The seven-day period is counted from leaving the risk area, which may differ from the date you arrive home. Write the itinerary and final risk-area departure date down before the appointment.

The product information advises taking the medicine with food or a milky drink to improve absorption. Vomiting and diarrhoea can affect treatment, so ask for product-specific instructions before travel rather than improvising repeat doses.

Tolerability and precautions

Possible effects include headache, abdominal pain, nausea, vomiting and diarrhoea. There is no universal “best tolerated” antimalarial for every traveller.

For malaria prevention, the UK product information contraindicates Malarone in severe renal impairment. This is more than a general suggestion to adjust the dose. Pregnancy, breastfeeding, allergies and interactions require individual review; the prevention choice may differ from treatment of an established infection.

Comparing options without a winner

Atovaquone/proguanil, doxycycline and mefloquine have different schedules and cautions. A short post-travel schedule may be convenient, but convenience alone cannot establish suitability. Ask about:

• The specific areas where prophylaxis is recommended.
• Pregnancy plans, kidney conditions and interactions.
• Previous reactions to antimalarials.
• A plan for missed doses, vomiting and access to urgent care.

Prevention beyond tablets

No preventive medicine provides complete protection. Use recommended mosquito-bite precautions. Fever during or after travel to a malaria-risk area needs immediate medical assessment; mention the itinerary even if you took all tablets.

For the platform process, see how independent online doctor assessment works. Prescrivia provides intermediary technology; independent clinicians decide suitability. A particular antimalarial, prescription, access or outcome is never guaranteed.

General information only, not medical advice. Follow the leaflet for your actual product and discuss decisions with a qualified clinician. See the current clinical, legal and language review statuses for this edition.

Sources

• GSK UK Malarone adult-tablet SmPC: P. falciparum indication, prevention schedule, food, renal contraindication and adverse effects.
• CDC Yellow Book 2026: itinerary-specific prevention, pregnancy restrictions, bite avoidance and fever assessment.

Sources checked online on 6 October 2026. UK and US guidance is identified as such; it does not establish availability or prescribing rules across all European countries.